- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Alexion Pharmaceuticals Inc. (ALXN)
by latest | most commented
-
Is IBB the Best Biotech ETF?
-
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
-
Wall Street Breakfast: Must-Know News
-
Where Might Genentech Investors Redeploy $47B?
-
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit
-
12 Stem Cell Stocks - Updated
-
Biopharma: Instead of M&A, Think P&A
-
IBB: Newfound Stability Lures Biotech Investors
-
I Like Haemonetics While Cognizant and Alexion Breed Concern
-
Wall Street Breakfast: Must-Know News
-
Hedge Fund Portfolio Tracking: Citadel Investment Group (Ken Griffin), Q3 2008
-
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
-
Even Fatter Yields for Pfizer; M&A Targets in the Sector
-
Stocks Potentially Impacted by SEC's Enforcement of Regulation SHO
-
5 Potential Buyout Targets in Biotech - Barron's
-
Tuesday Options Outlook: MER, C, CSC, TIE, PWAV, GPS, ALXN, ELNK
-
A Biotech Bloom in July
-
Biotech Buying Binge About to Begin?
-
Q1 Earnings 'Triple Plays'
-
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
-
Alexion Pharma: Bounce Play?
-
Top 7 BioPharma & Pharma Innovations of 2007
-
Nine Stem Cell Stocks to Add to Your Portfolio
-
Companies With The Most Analyst Attention & Affection
-
Loeb's Third Point Releases 13F Filing, Shows a Number of New Positions
-
Alexion Pharmaceuticals: Costs of Healthcare Rise to the Extreme
-
Conference Call With Alexion Leaves Credit Suisse Analyst Speechless
-
Biotech Day in Review: AtheroGenics Tumbles on Drug Test Failure
-
Investing in Stem Cell Stocks: Growth Industry of the Future?
-
Chart: Biotech Stocks - Annual Earnings Growth
-
Chart: Biotech Stocks - Quarterly Earnings Growth
-
Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
-
Chart: Biotech Stocks - Quarterly Revenue Growth
-
Chart: Biotech Stocks - Change in Cash-On-Hand
-
Chart: Biotech Stocks - Normalized Net Income Per Employee
-
Chart: Biotech Stocks - Revenue Per Employee
-
Chart: Biotech Stocks - Normalized Net Profit Margins
-
Chart: Biotech Stocks - SG&A Margin (MRQ)
-
Chart: Biotech Stocks - Gross Profit Margins
-
Chart: Biotechnology Companies - Annual Net Income Growth
-
Chart: Biotech Stocks - Annual Revenue Growth